Intelligent gene panel design can be a challenge because of the vast quantity of publicly-available biological information that needs to be aggregated and interpreted. Genomenon’s proprietary gene-disease-variant knowledge base and variant curation tool, Mastermind, significantly decreases the amount of time required to extract meaningful variant information from the biomedical literature. Contact us to learn more about how we can accelerate your next evidence-based panel design.
Our specialists review and rank the candidate biomarkers and reference citations before your final approval.
Complete Literature Citations
Candidate biomarkers for your NGS panel or assay come with a list of the top 10 literature citations.
Download White Paper to Learn More About Evidence-Based Gene Panel Design
Learn how to select biomarkers for an NGS panel from evidence found in the scientific literature. This white paper shows how evidence-based gene panels can be designed and includes a complete example of a pan-hematopoietic malignancy panel with 314 genes associated with leukemia and 311 genes associated with lymphoma.